Biblio Discovery — Demo Discovery Service

10 results for "Even H. Rustad"

Showing 1–10 · 1.05 seconds · RSS

  1. Journal Article

    mmsig: a fitting approach to accurately identify somatic mutational signatures in hematological malignancies

    Even H. Rustad; Ferran Nadeu; Nicos Angelopoulos et al.

    Communications Biology, Vol. 4 No. 1 · 2021 · English · DOAJ Scopus

    Rustad et al. present a software package for the R statistical environment for the accurately quantify of somatic mutational signatures in hematological malignancies

  2. Journal Article Full text

    Baseline identification of clonal V(D)J sequences for DNA-based minimal residual disease detection in multiple myeloma

    Even H. Rustad; Malin Hultcrantz; Venkata D. Yellapantula et al.

    PLOS ONE, Vol. 14 No. 3 · 2019 · English · PLOS Scopus

    Tracking of clonal immunoglobulin V(D)J rearrangement sequences by next generation sequencing is highly sensitive for minimal residual disease in multiple myeloma. However, previous studies have found variable rates of V(D)J sequence identification at baseline, which could limit tracking. Here, we…

    Also available at: DOAJ

  3. Journal Article

    Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma

    Kylee H. Maclachlan; Even H. Rustad; Andriy Derkach et al.

    Nature Communications, Vol. 12 No. 1 · 2021 · English · DOAJ Scopus

    Chromothripsis is associated with unfavourable outcomes in multiple myeloma (MM), but its detection usually requires whole genome sequencing. Here the authors develop an approach to detect chromothripsis in MM based on copy-number signatures that also works with whole exome sequencing data.

  4. Journal Article

    Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants

    Saskia Meyer; Isaac Blaas; Ravi Chand Bollineni et al.

    Cell Reports, Vol. 42 No. 1 · 2023 · English · DOAJ Scopus

    Summary: The emergence of SARS-CoV-2 variants of concern (VOC) is driven by mutations that mediate escape from neutralizing antibodies. There is also evidence that mutations can cause loss of T cell epitopes. However, studies on viral escape from T cell immunity have been hampered by uncertain…

  5. Journal Article

    The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma

    Eileen M. Boyle; Shayu Deshpande; Ruslana Tytarenko et al.

    Nature Communications, Vol. 12 No. 1 · 2021 · English · DOAJ Scopus

    Progression from asymptomatic smoldering multiple myeloma (SMM) to symptomatic Multiple Myeloma occurs at different rates in different patients. Here, the authors report fewer NRAS and FAM46C mutations and adverse translocations in SMM compared to MM, while KRAS mutations are associated with a…

  6. Journal Article

    Timing the initiation of multiple myeloma

    Even H. Rustad; Venkata Yellapantula; Daniel Leongamornlert et al.

    Nature Communications, Vol. 11 No. 1 · 2020 · English · DOAJ Scopus

    The initial mutational processes and how these lead to progression in multiple myeloma (MM) are unclear. Here, the authors identify mutational signatures that occur over time in a large cohort of MM patients and suggest features that may help in early diagnosis.

  7. Journal Article

    Author Correction: Accelerated single cell seeding in relapsed multiple myeloma

    Heather J. Landau; Venkata Yellapantula; Benjamin T. Diamond et al.

    Nature Communications, Vol. 12 No. 1 · 2021 · English · DOAJ Scopus

    A Correction to this paper has been published: https://doi.org/10.1038/s41467-021-20978-y.

  8. Journal Article

    Accelerated single cell seeding in relapsed multiple myeloma

    Heather J. Landau; Venkata Yellapantula; Benjamin T. Diamond et al.

    Nature Communications, Vol. 11 No. 1 · 2020 · English · DOAJ Scopus

    In multiple myeloma, disease progresses via seeding to different anatomic sites and clonal expansion. Here, utilising autopsy material, the authors show that systemic seeding accelerates at relapse following treatment.